Safety and Efficacy of Baloxavir Marboxil in Influenza-infected Children 5-11 Years of Age: A Post Hoc Analysis of a Phase 3 Study.

Baker, Jeffery B; Block, Stanley L; Cagas, Steven E; Macutkiewicz, Laura Burleigh; Collins, Colleen; Sadeghi, Mitra; Sarkar, Sriparna; Williams, Sarah

Baker, Jeffery B; Block, Stanley L; Cagas, Steven E; Macutkiewicz, Laura Burleigh; Collins, Colleen; Sadeghi, Mitra; Sarkar, Sriparna; Williams, Sarah.

Afiliación

Baker JB; From the Clinical Research Prime, Idaho Falls, Idaho.
Block SL; Kentucky Pediatric and Adult Research Inc, Bardstown, Kentucky.
Cagas SE; Genentech, Inc, South San Francisco, California.
Macutkiewicz LB; Roche Products Ltd, Welwyn Garden City, Hertfordshire, United Kingdom.
Collins C; Genentech, Inc, South San Francisco, California.
Sadeghi M; Genentech, Inc, South San Francisco, California.
Sarkar S; Roche Products Ltd, Welwyn Garden City, Hertfordshire, United Kingdom.
Williams S; Roche Products Ltd, Welwyn Garden City, Hertfordshire, United Kingdom.

Pediatr Infect Dis J ; 42(11): 983-989, 2023 Nov 01.

Article en En | MEDLINE | ID: mdl-37595103

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Pediatr Infect Dis J Asunto de la revista: DOENCAS TRANSMISSIVEIS / PEDIATRIA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google